3350 W Bayshore Rd Ste 150
Palo Alto CA 94303
Phone 650.646.3412

Pharmaceutical Backgrounder | Scientific Origins | The Next Wave | Biology-Centric Hypothesis
:: Value Proposition

"Oligasis Inside" medicines mean:
  • More creative product concepts
  • Higher commit-to-medicines-development matriculation rates
  • Higher efficacy medicines that "sell themselves" to the FDA, providers, payers, and patients

Our commercial strategy focuses on:

  • Manufacturing biopolymers
  • Establishing technology leadership for the discovery and development of biopolymer-modified drugs
  • Engaging in product driven collaborative research programs with biotech and pharma partners who have drugs and mechanistic hypotheses but lack the tools to bring them together into high efficacy, multi-functional medicines

Origins

Oligasis (o-LIG'-ah-sis) means cure the small one.  The Company has its origins in one of the cofounder's moments of inspiration: the drug formats used to build the current generation of medicines were not up to the task of creating a treatment for his young nephew's rare and fatal childhood disease.  He conceived of a new, flexible format crafted from intersecting thirty years of his scientific career.

Building on that insight, we have created a whole new way to imagine, design and build safer and higher efficacy medicines.